BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 13, 2006
View Archived Issues
Weekly DN-101 administration assessed in cancer patients
Read More
In vitro studies reveal effects of pirfenidone alone and with IFN-gamma-1B
Read More
Lestaurtinib, midostaurin cytotoxic in acute myeloid leukemia blasts
Read More
Novel anti-HLA-DR antibody may potentiate rituximab's antilymphoma activity
Read More
P. falciparum methionine aminopeptidase 1: novel target for antimalarial drugs
Read More
Small MRP1 inhibitor sensitizes resistant neuroblastoma tumors to chemotherapy
Read More
ADC-4022 for COPD and asthma enters clinic
Read More
Rivaroxaban phase III program outlined in stroke prevention and VTE
Read More
KB-002 studied in rheumatoid arthritis patients
Read More
ACR-325 enters clinic for treatment of psychosis
Read More
3M to sell global branded pharmaceuticals business
Read More
MedImmune files IND for cell culture-based influenza vaccine
Read More
MedImmune to sell CytoGam to ZLB Behring
Read More
Pozen submits full response to Trexima approvable letter
Read More
Phase IIb study evaluates AN-0128 in children with atopic dermatitis
Read More
Cardiovascular outcomes study not required for naproxcinod
Read More
UCB publishes offer document for takeover of Schwarz Pharma
Read More
IND filing for CollaRx Gentamicin in diabetic foot ulcers
Read More
GlycoPEG-GCSF studied in phase I trial
Read More
ARQ-501 demonstrates tolerability and signs of antitumor activity
Read More
Neurobiological Technologies makes case for Viprinex in stroke
Read More
Prochymal shows good complete response rate in GVHD
Read More
Recent patents describe novel antidiabetic agents
Read More
Novel cannabinoid CB1 receptor antagonists emerge from Pfizer R&D
Read More
Recent patents describe new compounds for thrombotic disorders
Read More
SLV-308 shows potential for concomitant treatment of parkinsonian symptoms
Read More
Lacosamide could be useful in essential tremor, dyskinetic side effects secondary to antipsychotics
Read More
AMPA receptor antagonist E-2007 shows positive effects as adjunct therapy to levodopa
Read More
Genentech to acquire Tanox
Read More
Mexican approval for Acomplia
Read More
Mirapex approved for restless legs syndrome
Read More
Presurgical bevacizumab/erlotinib safe and effective in RCC
Read More